Genomic Profiling of Premenopausal HR+ and HER2– Metastatic Breast Cancer by Circulating Tumor DNA and Association of Genetic Alterations With Therapeutic Response to Endocrine Therapy and Ribociclib

Bardia A.Su F.Solovieff N.Im S.-A.Sohn J.Lee K.S.Campos-Gomez S.Jung K.H.Colleoni M.V?zquez R.V.Franke F.Hurvitz S.Harbeck N.Chow L.Taran T.Lorenc K.R.Babbar N.Tripathy D.YEN-SHEN LU2022-03-102022-03-1020212473-4284https://www.scopus.com/inward/record.uri?eid=2-s2.0-85117691150&doi=10.1200%2fPO.20.00445&partnerID=40&md5=3d8032dd35441f49ce15851ef671a123https://scholars.lib.ntu.edu.tw/handle/123456789/597071[SDGs]SDG3Genomic Profiling of Premenopausal HR+ and HER2– Metastatic Breast Cancer by Circulating Tumor DNA and Association of Genetic Alterations With Therapeutic Response to Endocrine Therapy and Ribociclibjournal article10.1200/PO.20.004452-s2.0-85117691150